Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria
Year: 2014
Type: article
Source: Journal of Clinical Microbiology
DOI: 10.1128/jcm.00782-14
Institutions: University of Iowa Hospitals and Clinics, JMI Laboratories
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Pfizer, Astellas Pharma
OpenAlex ID: W4245165711
